# Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-dapagliflozin-versus-sitagliptin-on-cardiometabolic-risk-factors-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ayako Fuchigami,Fumika Shigiyama,Toru Kitazawa,Yosuke Okada,Takamasa Ichijo,Mariko Higa,Toru Hiyoshi,Ikuo Inoue,Kaoru Iso,Hidenori Yoshii,Takahisa Hirose,Naoki Kumashiro |
| Citations | 126 |
| DOI | 10.1186/s12933-019-0977-z |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0977-z |
| OpenAlex ID | https://openalex.org/W3004109662 |
| PMID | 31910850 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yosuke Okada](https://scholariq.org/researchers/yosuke-okada/)

## Paper journal

- [Cardiovascular Diabetology](https://scholariq.org/journals/cardiovascular-diabetology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.